12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Pfizer, Takeda sales and marketing update

Pfizer and Takeda launched Xeljanz tofacitinib in Japan to treat rheumatoid arthritis in adult patients who have an inadequate response to existing therapies. Pfizer said...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >